CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

The Lancet Oncology
Michael PfreundschuhMabThera International Trial Group

Abstract

The role of rituximab in combination with different CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)-like chemotherapy regimens in young patients with good-prognosis diffuse large-B-cell lymphoma remains to be defined. We aimed to compare CHOP-like chemotherapy and rituximab with CHOP-like chemotherapy alone in these patients. 824 patients who were from 18 countries; aged 18-60 years; and who had no risk factors or one risk factor according to age-adjusted International Prognostic Index (IPI), stage II-IV disease, or stage I disease with bulk were enrolled. These patients were randomly assigned to six cycles of CHOP-like chemotherapy and rituximab (n=413) or to six cycles of CHOP-like chemotherapy alone (n=411). Bulky and extranodal sites received additional radiotherapy. The primary endpoint was event-free survival; secondary endpoints were response, progression under therapy, progression-free survival, overall survival, and frequency of toxic effects. Analyses were done by intention to treat and per protocol. This trial is registered at http://www.clinicaltrials.gov, NCT 00064116. After a median follow-up of 34 months (range 0.03-61), patients assigned chemotherapy and rituximab had increased 3-year event-fre...Continue Reading

References

Mar 25, 2005·The New England Journal of Medicine·Félix ReyesUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA)

❮ Previous
Next ❯

Citations

May 24, 2013·European Journal of Clinical Pharmacology·I DanésJ A Bosch
Oct 12, 2007·Annals of Hematology·Moritz PalmowskiPeter Hallscheidt
Oct 15, 2008·Annals of Hematology·T FietzUNKNOWN East German Study Group on Hematology and Oncology-OSHO
Aug 21, 2009·Annals of Hematology·Michael A FridrikRichard Greil
Sep 4, 2009·Annals of Hematology·Andrea BorgerdingLorenz Trümper
Jul 4, 2012·Annals of Hematology·Byeong Seok SohnCheolwon Suh
Jun 21, 2007·Cancer Chemotherapy and Pharmacology·Frank P KroschinskyEberhard Schleyer
Jul 16, 2011·Cancer Chemotherapy and Pharmacology·John L ReaganAnthony E Mega
Aug 19, 2007·Journal of Cancer Research and Clinical Oncology·Kristen N GanjooCaroline S An
Jan 20, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ulrich J M MeyMarcus Gorschlueter
Nov 1, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Junshik HongJae Hoon Lee
May 3, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Linda S EltingUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Dec 20, 2011·Medical Molecular Morphology·Norifumi TsukamotoYoshihisa Nojima
Oct 12, 2007·International Journal of Clinical Oncology·Kensei Tobinai
Jun 29, 2011·International Journal of Clinical Oncology·Shuzo HamamotoKenjiro Kohri
Feb 22, 2011·Cancer Causes & Control : CCC·Peter D BaadeLin Fritschi
Jun 8, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Sebastien DroletW Donald Buie
Feb 3, 2012·Current Treatment Options in Oncology·Murali JanakiramAdam M Petrich
Oct 1, 2007·Current Hematologic Malignancy Reports·Jane N Winter

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Pierre FeugierBertrand Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Thomas M HabermannSandra J Horning
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Laurie H SehnJ M Connors
© 2022 Meta ULC. All rights reserved